In a study of 129 random blood samples, mCD163 has been shown to be inversely related to the plasma levels of sCD163 [15] and in another study proteolytic shedding of CD163 has been shown to be increased in serum of MS patients [16]. This evidence concerns the gene CD163 and myeloid sarcoma.